These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36046643)

  • 1. Erratum: MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2: Erratum.
    Wang Y; Chang W; Chang W; Chang X; Zhai S; Pan G; Dang S
    J Cancer; 2022; 13(10):3135-3136. PubMed ID: 36046643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2: Erratum.
    Wang Y; Chang W; Chang W; Chang X; Zhai S; Pan G; Dang S
    J Cancer; 2024; 15(7):1898-1900. PubMed ID: 38434986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway.
    Cao X; Zhang J; Apaer S; Yao G; Li T
    Int J Gen Med; 2021; 14():89-102. PubMed ID: 33469348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2: Erratum.
    Yang X; Sun J; Sun H; Wen B; Zhang M; An H; Chen W; Zhao W; Zhong X; He C; Pang J; He S
    J Cancer; 2022; 13(14):3593-3594. PubMed ID: 36484010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum.
    Yang L; Guo Y; Liu X; Wang T; Tong X; Lei K; Wang J; Huang D; Xu Q
    J Cancer; 2022; 13(10):3133-3134. PubMed ID: 36046657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of miR-376c-3p/SYF2 Axis on the Progression of Gastric Cancer.
    Liu B; Li G; Zhang Z; Wu H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819874808. PubMed ID: 31522605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum.
    Xie Z; Dang Y; Wu H; He R; Ma J; Peng Z; Rong M; Li Z; Yang J; Jiang Y; Chen G; Yang L
    J Cancer; 2022; 13(4):1386-1387. PubMed ID: 35281854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: Erratum.
    Liu W; Feng Q; Liao W; Li E; Wu L
    J Cancer; 2024; 15(16):5132-5133. PubMed ID: 39247611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibited HDAC3 promotes microRNA-376c-3p to suppress malignant phenotypes of gastric cancer cells by reducing WNT2b.
    Zhang L; Liu F; Meng Z; Luo Q; Pan D; Qian Y
    Genomics; 2021 Nov; 113(6):3512-3522. PubMed ID: 34284078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis.
    Ma Y; Cong X; Zhang Y; Yin X; Zhu Z; Xue Y
    Cancer Cell Int; 2020; 20():81. PubMed ID: 32190005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc01278 inhibits the development of papillary thyroid carcinoma by regulating miR-376c-3p/DNM3 axis.
    Lin S; Tan L; Luo D; Peng X; Zhu Y; Li H
    Cancer Manag Res; 2019; 11():8557-8569. PubMed ID: 31572010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells: Erratum.
    Hong YG; Xin C; Zhou JD; Gao XH; Hao L; Liu QZ; Zhang W; Hao LQ
    J Cancer; 2023; 14(2):318-321. PubMed ID: 36741264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells [Erratum].
    Onco Targets Ther; 2018; 11():2203. PubMed ID: 29714361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G
    Luo Q; Guo F; Fu Q; Sui G
    Mol Ther Nucleic Acids; 2022 Mar; 27():593-597. PubMed ID: 35036068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Circular RNA Hsa_circRNA_101996 promotes the development of Gastric Cancer via Upregulating Matrix Metalloproteinases-2/Matrix Metalloproteinases-9 through MicroRNA-143/Ten-eleven translocation-2 Pathway: Erratum.
    Huang F; Jiang J; Yao Y; Hu S; Wang H; Zhu M; Yu L; Liu Q; Jia H; Xu W
    J Cancer; 2024; 15(9):2805-2809. PubMed ID: 38577614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.
    Bhavsar SP; Løkke C; Flægstad T; Einvik C
    Oncol Lett; 2018 Nov; 16(5):6786-6794. PubMed ID: 30405823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic preconditioning-induced protective effect for promoting angiogenesis in renal ischemia-reperfusion injury by regulating miR-376c-3p/HIF-1α/VEGF axis in male rats.
    Xue J; Zhu K; Cao P; Long C; Deng Y; Liu T; Yin G; Li X; Wang Z
    Life Sci; 2022 Jun; 299():120357. PubMed ID: 35092734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways: Erratum.
    Ma M; Dai J; Tang H; Xu T; Yu S; Si L; Cui C; Sheng X; Chi Z; Mao L; Wu X; Yang L; Yu H; Li S; Lian B; Tang B; Wang X; Yan X; Bai X; Zhou L; Kong Y; Guo J
    Theranostics; 2022; 12(7):3578-3579. PubMed ID: 35547776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum to miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1.
    Editorial Office
    Ann Transl Med; 2022 Oct; 10(19):1076. PubMed ID: 36330407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma: Erratum.
    Liu Y; Yao Y; Liao B; Zhang H; Yang Z; Xia P; Jiang X; Ma W; Wu X; Mei C; Wang G; Gao M; Xu K; GongYe X; Cheng Z; Jiang P; Chen X; Yuan Y
    Int J Biol Sci; 2023; 19(10):3292. PubMed ID: 37416773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.